Janus Henderson Group plc 13D and 13G filings for iTeos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 12:09 pm Sale |
2021-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
JANUS HENDERSON GROUP PLC JHG |
3,533 0.000% |
-1,984,597 (-99.82%) |
Filing |
| 2021-02-12 3:39 pm Purchase |
2020-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
JANUS HENDERSON GROUP PLC JHG |
1,988,130 5.700% |
1,988,130 (New Position) |
Filing |